Federal Court Dismisses Illumina Patent Infringement Suit against Affymetrix | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A US federal court has dismissed Illumina lawsuits alleging Affymetrix infringes on patents covering array technologies.

In a decision handed down on Tuesday, Judge Barbara Crabb of the US District Court for the Western District of Wisconsin granted summary judgment for Santa Clara, Calif.-based Affymetrix, saying the company does not infringe on US Patent numbers 7,510,841 and 7,612,020 and dismissed the cases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.